Skip to content

Predicting Ipsilesional Motor Deficits in Stroke With Dynamic Dominance Model

Predicting Ipsilesional Motor Deficits in Stroke With Dynamic Dominance Model

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03634397
Enrollment
58
Registered
2018-08-16
Start date
2019-02-02
Completion date
2024-08-05
Last updated
2025-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

This study will test the hypothesis that the combination of low-moderate to severe motor deficits in the paretic arm and persistent motor deficits in the less-impaired arm limits functional independence in chronic stroke survivors. We, therefore, predict that intense remediation, focused on improving the speed, coordination, and accuracy of the less-impaired arm should improve functional independence.

Detailed description

We previously characterized hemisphere-specific motor control deficits in the non-paretic arm of unilaterally lesioned stroke survivors. Our preliminary data indicate these deficits are substantial and functionally limiting in patients with severe paresis. We have specifically designed an intervention to remediate the hemisphere-specific deficits in the less-impaired arm, using a virtual-reality platform, and then follow this training with manipulation training of a variety of real objects, designed to facilitate generalization and transfer to functional behaviors encountered in the natural environment. We propose a 2-site, two-group randomized intervention with a treatment group, which will receive unilateral training of the less-impaired arm, through our Virtual Reality and Manipulation Training (VRMT) protocol. This intervention protocol is grounded in the premise that targeted remediation of fundamental control deficits exhibited by the less-impaired arm will generalize and transfer beyond practiced tasks to performance of activities of daily living (ADL). This approach contrasts with the more pragmatic approach of task-specific training of essential ADL's, which is limited in scope, more cumbersome, and ignores known fundamental motor control deficits. Our control group will receive conventional intervention, guided by recently released practice guidelines for upper limb intervention in adult stroke. The impact of the proposed research is that we address persistent functional performance deficits in chronic stroke patients with severe paresis, who's less-impaired arm impairments are generally ignored in most current rehabilitation protocols. Our first aim addresses the overall effectiveness of this intervention, relative to our control group: To determine whether non-paretic arm VRMT in chronic stroke survivors with severe paresis will produce durable improvements in less-impaired arm motor performance that will generalize to improve functional activities and functional independence to a greater extent than conventional therapy focused on the paretic arm. Our second aim focuses on the mechanistic basis of potential training-related improvements in motor performance: To determine whether intervention-induced improvements in less-impaired arm performance are associated with improvements in hemisphere-specific reaching kinematics. Finally, our third aim monitors for potential negative effects of our experimental intervention on paretic arm impairment.

Interventions

BEHAVIORALLess-Impaired Arm Training

Participants receive virtual reality and manipulation training in their less impaired arm.

BEHAVIORALContralesional Arm Comparison

Participants receive therapy in their paretic arm, based on the best-practices framework for arm recovery post stroke.

Sponsors

University of Southern California
CollaboratorOTHER
Penn State University
CollaboratorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
Robert L. Sainburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The outcome assessor will assess all participants and be unaware of the participants' group assignment.

Intervention model description

Participants are randomly assigned to one of two groups. One group (treatment group) receives remediation therapy of the less impaired arm while the control group receives paretic arm therapy.

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. neuroradiological confirmation of unilateral brain damage with residual contralesional upper-extremity weakness 2. deficits in ipsilesional arm performance assessed by the JTHFT 3. 6+ months post stroke 4. Demonstrates cognitive abilities

Exclusion criteria

a history of: 1. neurological disease other than stroke (e.g., head trauma) 2. a major psychiatric diagnosis (e.g., schizophrenia, major affective disorder), 3. hospital admission for substance abuse 4. peripheral disorders affecting sensation or movement of the upper extremities, including pain or arthritis 5. currently taking prescription drugs with known sedative properties that are interfering with sensory-motor function 6. significant joint pain that is activity limiting 7. bilateral stroke

Design outcomes

Primary

MeasureTime frameDescription
Change in Jebsen-Taylor Hand Function Test (JTHFT) Times From Baseline 2 to Post Test 1Baseline 2 to Post Test 1 (up to 2 weeks post last treatment session)Measure of unimanual arm performance in a wide range of hand functions required for activities of daily living. The test includes 7 timed (seconds) activities (possible 0-120 seconds each); the analysis excludes the writing component, therefore it includes 6 of the 7 original JTHFT components. Faster performance yields lower scores (time). There were 2 baseline tests (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score as the starting value and do not include the first baseline scores.
Change in Abilhand Scores From Baseline 2 (Prior to Treatment) to Post Test 1Baseline 2 to Post Test 1 (up to 2 weeks post last treatment session)Participant reported outcome of difficulty of upper extremity based activities. Scores are transformed to logit scores. The items ranged on the interval scale from -2.18 to 1.72 log-odds units, called 'logits', with higher logit values indicating more difficult activities. Deltas of logits from baseline 2 to post test 1 are reported. There were two baseline assessments (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score (when participants were randomized) as the starting value and do not include the first baseline scores. Results do not include covariates.
Change of Score on Barthel Index From Baseline 2 (Prior to Training) to Post Test 1Baseline 2 to Post Test 1 (up to 2 weeks post last treatment session)Measure of functional independence in self care activities scored from 0-100 with higher scores indicating more functional independence. There were two baseline assessments (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score (when participants were randomized) as the starting value and do not include the first baseline scores.
Change in Upper-Extremity Fugl-Meyer Assessment (FM) Score From Baseline 2 (Prior to Training) to Post Test 1Baseline 2 to Post Test 1 (up to 2 weeks post last treatment session)Upper-Extremity Measure of paretic arm impairment out of 66 possible points with higher scores indicating more movement, and 0 indicating no functional movement in the arm. There were two baseline assessments (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score (when participants were randomized) as the starting value and do not include the first baseline scores.

Secondary

MeasureTime frameDescription
Change From Baseline 2 (Prior to Training) to Post Test 1 on Contralesional Work Space Area (Kinematics)Baseline 2 to Post Test 1 (up to 2 weeks post last treatment session)Workspace area is a kinematic measure of active range of motion, which we measured on the paretic (contralesional) arm. This was calculated by computing the area of the ellipse (measured in centimeters) formed by the major and minor axis of the contralesional arm trajectory on each trial. The major axis was defined as the largest distance between any two points in the handpath, while the minor axis was defined as the largest distance, perpendicular to the major axis. Values were averaged within subjects over all trials for each evaluation (i.e. BL2 and PT1), then group and evaluation averages and standard deviations were calculated from these values. There were two baseline tests (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score as the starting value and do not include the first baseline scores. These values do not include covariates.
Change in Kinematics- Positional Variability at Maximum Velocity From Baseline 2 (Prior to Training) to Post Test 1Baseline 2 to Post Test 1 (up to 2 weeks post last treatment session)Positional variability is a measure of kinematic variability in reaching movement. This was measured at the participants max reaching velocity and their end position. This was calculated by taking the distance (cm) from the fingertips location at peak velocity/end position on a given trial from its mean location at peak velocity/end position across all trials, for each target. Values were averaged within subjects over all trials for each evaluation (i.e. BL2 and PT1), then group and evaluation averages and standard deviations were calculated from these values. There were two baseline tests (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score as the starting value and do not include the first baseline scores or covariates.
Change From Baseline 2 (Prior to Training) to Post Test 1on Functional Independence Measure (FIM) -Self Care ComponentsBaseline 2 to Post Test 1 (up to 2 weeks post last treatment session)Each item on the FIM is scored on a 7-point Likert scale, and the score indicates the amount of assistance required to perform each item (1 = total assistance in all areas, 7 = total independence in all areas). Analysis includes 6 sub-components of the FIM, which are the self care components (Eating, Grooming, Bathing, Dressing upper body, Dressing lower body, and toileting) (possible 42 points). Higher scores indicate more independence. There were two baseline tests (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score as the starting value and do not include the first baseline scores.

Countries

United States

Participant flow

Participants by arm

ArmCount
Ipsilesional Arm Training (Experimental Condition)
Intervention condition includes therapy of the less-impaired ipsilesional arm. Ipsilesional Arm Training: Participants receive virtual reality and manipulation training in their less impaired arm.
29
Contralesional Arm (Comparison Condition)
Comparison control condition includes therapy of the paretic (contralesional) arm. Contralesional Arm Comparison: Participants receive therapy in their paretic arm, based on the best-practices framework for arm recovery post stroke.
29
Total58

Baseline characteristics

CharacteristicIpsilesional Arm Training (Experimental Condition)Contralesional Arm (Comparison Condition)Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
8 Participants9 Participants17 Participants
Age, Categorical
Between 18 and 65 years
21 Participants20 Participants41 Participants
Age, Continuous58 years59 years59 years
Jebsen-Taylor Hand Function Test29 Participants29 Participants58 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants3 Participants4 Participants
Race (NIH/OMB)
Black or African American
4 Participants2 Participants6 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
23 Participants23 Participants46 Participants
Region of Enrollment
United States
29 participants29 participants58 participants
Sex: Female, Male
Female
9 Participants9 Participants18 Participants
Sex: Female, Male
Male
20 Participants20 Participants40 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 290 / 29
other
Total, other adverse events
2 / 294 / 29
serious
Total, serious adverse events
2 / 291 / 29

Outcome results

Primary

Change in Abilhand Scores From Baseline 2 (Prior to Treatment) to Post Test 1

Participant reported outcome of difficulty of upper extremity based activities. Scores are transformed to logit scores. The items ranged on the interval scale from -2.18 to 1.72 log-odds units, called 'logits', with higher logit values indicating more difficult activities. Deltas of logits from baseline 2 to post test 1 are reported. There were two baseline assessments (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score (when participants were randomized) as the starting value and do not include the first baseline scores. Results do not include covariates.

Time frame: Baseline 2 to Post Test 1 (up to 2 weeks post last treatment session)

Population: All participants with baseline 2 and post test 1 data were included in analysis. Scores are transformed to logit scores. The items ranged on the interval scale from -2.18 to 1.72 log-odds units, called 'logits', with higher logit values indicating more difficult activities. Deltas of logits from baseline 2 to post test 1 are reported.

ArmMeasureValue (MEAN)Dispersion
Ipsilesional Arm Training (Experimental Condition)Change in Abilhand Scores From Baseline 2 (Prior to Treatment) to Post Test 1-2.08 score on a scaleStandard Error 1.43
Contralesional Arm (Comparison Condition)Change in Abilhand Scores From Baseline 2 (Prior to Treatment) to Post Test 1-.57 score on a scaleStandard Error 1.18
Primary

Change in Jebsen-Taylor Hand Function Test (JTHFT) Times From Baseline 2 to Post Test 1

Measure of unimanual arm performance in a wide range of hand functions required for activities of daily living. The test includes 7 timed (seconds) activities (possible 0-120 seconds each); the analysis excludes the writing component, therefore it includes 6 of the 7 original JTHFT components. Faster performance yields lower scores (time). There were 2 baseline tests (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score as the starting value and do not include the first baseline scores.

Time frame: Baseline 2 to Post Test 1 (up to 2 weeks post last treatment session)

Population: 5 participants were randomized, but did not complete intervention due to Covid epidemic, and thus did not have JTHFT at post test 1.

ArmMeasureValue (MEAN)Dispersion
Ipsilesional Arm Training (Experimental Condition)Change in Jebsen-Taylor Hand Function Test (JTHFT) Times From Baseline 2 to Post Test 15.07 secondsStandard Error 0.93
Contralesional Arm (Comparison Condition)Change in Jebsen-Taylor Hand Function Test (JTHFT) Times From Baseline 2 to Post Test 1-.11 secondsStandard Error 1.37
p-value: <0.0595% CI: [2.31, 9.14]Regression, Linear
Primary

Change in Upper-Extremity Fugl-Meyer Assessment (FM) Score From Baseline 2 (Prior to Training) to Post Test 1

Upper-Extremity Measure of paretic arm impairment out of 66 possible points with higher scores indicating more movement, and 0 indicating no functional movement in the arm. There were two baseline assessments (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score (when participants were randomized) as the starting value and do not include the first baseline scores.

Time frame: Baseline 2 to Post Test 1 (up to 2 weeks post last treatment session)

Population: Only participants with data at baseline 2 and post test 1 are included in analysis.

ArmMeasureValue (MEAN)Dispersion
Ipsilesional Arm Training (Experimental Condition)Change in Upper-Extremity Fugl-Meyer Assessment (FM) Score From Baseline 2 (Prior to Training) to Post Test 1-.68 score on a scaleStandard Error 0.8
Contralesional Arm (Comparison Condition)Change in Upper-Extremity Fugl-Meyer Assessment (FM) Score From Baseline 2 (Prior to Training) to Post Test 1-1.61 score on a scaleStandard Error 0.93
p-value: <0.0595% CI: [-2.29, 4.53]Regression, Linear
Primary

Change of Score on Barthel Index From Baseline 2 (Prior to Training) to Post Test 1

Measure of functional independence in self care activities scored from 0-100 with higher scores indicating more functional independence. There were two baseline assessments (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score (when participants were randomized) as the starting value and do not include the first baseline scores.

Time frame: Baseline 2 to Post Test 1 (up to 2 weeks post last treatment session)

Population: Only participants with baseline 2 and post test 1 are included in analysis. Delta values from baseline 2 to post test 1 are reported and adjusted for age, sex, and hemisphere of lesion.

ArmMeasureValue (MEAN)Dispersion
Ipsilesional Arm Training (Experimental Condition)Change of Score on Barthel Index From Baseline 2 (Prior to Training) to Post Test 1-1.2 score on a scaleStandard Error 1.83
Contralesional Arm (Comparison Condition)Change of Score on Barthel Index From Baseline 2 (Prior to Training) to Post Test 1-1.79 score on a scaleStandard Error 1.24
p-value: <0.0595% CI: [-2.58, 4.24]Regression, Linear
Secondary

Change From Baseline 2 (Prior to Training) to Post Test 1 on Contralesional Work Space Area (Kinematics)

Workspace area is a kinematic measure of active range of motion, which we measured on the paretic (contralesional) arm. This was calculated by computing the area of the ellipse (measured in centimeters) formed by the major and minor axis of the contralesional arm trajectory on each trial. The major axis was defined as the largest distance between any two points in the handpath, while the minor axis was defined as the largest distance, perpendicular to the major axis. Values were averaged within subjects over all trials for each evaluation (i.e. BL2 and PT1), then group and evaluation averages and standard deviations were calculated from these values. There were two baseline tests (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score as the starting value and do not include the first baseline scores. These values do not include covariates.

Time frame: Baseline 2 to Post Test 1 (up to 2 weeks post last treatment session)

Population: Participants were excluded from this analysis if they could not complete the kinematics for any reason (i.e.: Covid, a pacemaker, not fitting in the kinematic setup), or did not complete both baseline and post test 1 kinematic assessments.

ArmMeasureValue (MEAN)Dispersion
Ipsilesional Arm Training (Experimental Condition)Change From Baseline 2 (Prior to Training) to Post Test 1 on Contralesional Work Space Area (Kinematics)0.512 centimetersStandard Deviation 2.1217
Contralesional Arm (Comparison Condition)Change From Baseline 2 (Prior to Training) to Post Test 1 on Contralesional Work Space Area (Kinematics)0.340 centimetersStandard Deviation 1.6714
Secondary

Change From Baseline 2 (Prior to Training) to Post Test 1on Functional Independence Measure (FIM) -Self Care Components

Each item on the FIM is scored on a 7-point Likert scale, and the score indicates the amount of assistance required to perform each item (1 = total assistance in all areas, 7 = total independence in all areas). Analysis includes 6 sub-components of the FIM, which are the self care components (Eating, Grooming, Bathing, Dressing upper body, Dressing lower body, and toileting) (possible 42 points). Higher scores indicate more independence. There were two baseline tests (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score as the starting value and do not include the first baseline scores.

Time frame: Baseline 2 to Post Test 1 (up to 2 weeks post last treatment session)

Population: All participants with baseline 2 and post test 1 data were analyzed (N=53). 5 randomized participants were excluded from analysis because they did not have baseline 2 and post test 1 measures due to Covid disruption.

ArmMeasureValue (MEAN)Dispersion
Ipsilesional Arm Training (Experimental Condition)Change From Baseline 2 (Prior to Training) to Post Test 1on Functional Independence Measure (FIM) -Self Care Components-1.44 score on a scaleStandard Error 0.75
Contralesional Arm (Comparison Condition)Change From Baseline 2 (Prior to Training) to Post Test 1on Functional Independence Measure (FIM) -Self Care Components-.46 score on a scaleStandard Error 0.81
Secondary

Change in Kinematics- Positional Variability at Maximum Velocity From Baseline 2 (Prior to Training) to Post Test 1

Positional variability is a measure of kinematic variability in reaching movement. This was measured at the participants max reaching velocity and their end position. This was calculated by taking the distance (cm) from the fingertips location at peak velocity/end position on a given trial from its mean location at peak velocity/end position across all trials, for each target. Values were averaged within subjects over all trials for each evaluation (i.e. BL2 and PT1), then group and evaluation averages and standard deviations were calculated from these values. There were two baseline tests (3 weeks apart) to show unchanged performance in assessments prior to training. Training included 15 sessions over the course of up to 7 weeks. Results reported used the second baseline score as the starting value and do not include the first baseline scores or covariates.

Time frame: Baseline 2 to Post Test 1 (up to 2 weeks post last treatment session)

Population: Participants were excluded if they could not complete the kinematic portion of the study due to Covid, or a pacemaker, or not fitting in the kinematic setup, or if they didn't complete both baseline and post test 1 assessments.

ArmMeasureGroupValue (MEAN)Dispersion
Ipsilesional Arm Training (Experimental Condition)Change in Kinematics- Positional Variability at Maximum Velocity From Baseline 2 (Prior to Training) to Post Test 1Maximum Velocity0.0930727 CentimetersStandard Deviation 0.4369149
Ipsilesional Arm Training (Experimental Condition)Change in Kinematics- Positional Variability at Maximum Velocity From Baseline 2 (Prior to Training) to Post Test 1End Position0.2811583 CentimetersStandard Deviation 0.5066384
Contralesional Arm (Comparison Condition)Change in Kinematics- Positional Variability at Maximum Velocity From Baseline 2 (Prior to Training) to Post Test 1Maximum Velocity-0.0225708 CentimetersStandard Deviation 0.4979299
Contralesional Arm (Comparison Condition)Change in Kinematics- Positional Variability at Maximum Velocity From Baseline 2 (Prior to Training) to Post Test 1End Position-0.1156399 CentimetersStandard Deviation 1.1076122

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026